(Q84210214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Experimental and clinical characteristics in myelodysplastic syndrome patients with or without HLA-DR15 allele (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

main subject

myelodysplastic syndrome

1 reference

Li Xiao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Liao Qiong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Zhang Yan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Zhang Zheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Song Luxi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Xu Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Tao Ying

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Liu Yizhi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Pu Quan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Hematological Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

98-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome

2 February 2020

cites work

1 reference

7 January 2021

Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles

1 reference

7 January 2021

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

1 reference

7 January 2021

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

1 reference

7 January 2021

Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele

1 reference

7 January 2021

The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

1 reference

7 January 2021

Proposals for the classification of the myelodysplastic syndromes

1 reference

7 January 2021

HLA class II nucleotide sequences, 1992

1 reference

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

7 January 2021

Detection of intracellular cytokines by flow cytometry

1 reference

7 January 2021

Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells

1 reference

7 January 2021

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

1 reference

7 January 2021

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

1 reference

7 January 2021

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

1 reference

7 January 2021

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.907

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19593744%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference